IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.
Acta Otorhinolaryngol Ital. 2021 Jun;41(3):248-254. doi: 10.14639/0392-100X-N0881.
To evaluate medium/long term outcomes and patient satisfaction through relief of symptoms and improved quality of life (QoL) after Jones tube conjunctivodacryocystorhinostomy (JT-CDCR) using the Naso Lacrimal Duct Obstruction symptom-score (NLDO-SS).
We conducted a retrospective, non-comparative, multicentric study including patients with complete obstruction of the superior and inferior proximal lacrimal drainage system. All patients underwent JT-CDCR, and the patency of the tube was evaluated with saline irrigation and endoscopic examination. We assessed patient satisfaction and quality of life administering the NLDO-SS.
We enrolled 16 patients, for a total of 21 eyes operated. The success rate for procedures was 81%. The success rate for single parameters was globally 95.9%; if considered separately, ocular symptoms and nasal symptoms were respectively 94.3% and 100%.
JT-CDCR was a reliable procedure, able to solve symptoms in a majority of patients and guaranteed a good quality of life over a long period of time.
通过使用 Naso Lacrimal Duct Obstruction symptom-score (NLDO-SS) 评估 Jones 管结膜囊鼻腔吻合术 (JT-CDCR) 后症状缓解和生活质量 (QoL) 改善的中/长期结果和患者满意度。
我们进行了一项回顾性、非对照、多中心研究,纳入了完全性上下泪道近端阻塞的患者。所有患者均接受 JT-CDCR 治疗,并通过盐水冲洗和内镜检查评估导管通畅性。我们通过 NLDO-SS 评估患者满意度和生活质量。
我们共纳入 16 名患者,共 21 只眼接受手术。手术成功率为 81%。单一参数的成功率总体为 95.9%;如果分别考虑,眼部症状和鼻部症状的成功率分别为 94.3%和 100%。
JT-CDCR 是一种可靠的手术方法,能够解决大多数患者的症状,并在很长一段时间内保证良好的生活质量。